Herbalife Nutrition Announces Full Year Record Results for the Second Consecutive Year
Herbalife Nutrition reported a record net sales of $5.8 billion for 2021, reflecting a 4.7% increase from 2020. The reported diluted EPS stood at $4.13, while adjusted diluted EPS was $4.79, marking increases of 49% and 29%, respectively. However, fourth-quarter sales dropped 6.6% year-over-year to $1.3 billion. For 2022, the company projects net sales growth between 0% and 6% and adjusted diluted EPS guidance of $4.25 to $4.75, amid rising supply chain costs.
- Record net sales of $5.8 billion in 2021, up 4.7% year-over-year.
- Reported diluted EPS of $4.13 and adjusted diluted EPS of $4.79, increases of 49% and 29% respectively.
- 2021 net income reached $447 million and adjusted EBITDA was $874 million, both records.
- Share repurchases of approximately $983 million during the year.
- 2.9 million new distributors added in 2021, with a retention rate of 68.9%.
- Fourth-quarter 2021 net sales decreased by 6.6% compared to Q4 2020.
- 2021 sales in China fell by 22.2%, with a significant decline in volume points.
- Expectations of adjusted EPS and EBITDA being impacted by inflationary pressures.
- Potential currency headwinds projected for 2022 guidance.
Annual Records Include:
Provides Guidance Including FY 2022
Herbalife Nutrition Full Year 2021 Earnings Infographic
“Global trends continue to drive demand for our science-backed nutrition products, resulting in another record year for Herbalife Nutrition,” said
HIGHLIGHTS
-
Full year 2021 net sales of
$5.8 billion 4.7% compared to full year 2020, representing the largest annual net sales result in Company history. The Company’s three largest regions:Asia Pacific ,North America and EMEA, each set annual net sales records.
-
Full year 2021 reported diluted EPS of
$4.13 $4.79 49% and29% , respectively, compared to the full year 2020 reported and adjusted1 diluted EPS of$2.77 $3.71
-
Full year 2021 reported net income of
$447.2 million $873.5 million
-
During the full year, the Company repurchased approximately 20.4 million shares for a total purchase price of
$983 million
-
Fourth quarter 2021 net sales of
$1.3 billion 6.6% compared to the fourth quarter 2020.
-
Fourth quarter 2021 reported diluted EPS of
$0.37 $0.57 $0.59 $0.71
-
Fourth quarter 2021 reported net income of
$38.2 million $131.6 million
-
Initiating FY 2022 net sales guidance range of
0% -6% growth, adjusted2 diluted EPS guidance range of$4.25 $4.75 $785 million $845 million $50 million
____________________
1 Adjusted diluted EPS and adjusted EBITDA are non-GAAP measures. See Schedule A – “Reconciliation of Non-GAAP Financial Measures” for a detailed reconciliation of these measures to the most directly comparable GAAP measure, and a discussion of why we believe these non-GAAP measures are useful.
2 Adjusted diluted EPS and adjusted EBITDA are non-GAAP measures. See the “Outlook” discussion below and the related footnotes and Schedule A – “Reconciliation of Non-GAAP Financial Measures” for additional information regarding adjusted diluted EPS and adjusted EBITDA guidance.
MANAGEMENT COMMENTARY
“Global trends continue to drive demand for our science-backed nutrition products, resulting in another record year for Herbalife Nutrition,” said Chairman and CEO
In 2021, the number of distributors continued to grow as more individuals are seeking entrepreneurial and flexible business opportunities, while fulfilling the increasing global demand for health & wellness products. Over the course of the year the Company added 2.9 million new distributors and preferred members. Additionally, the Company announced record sales leader retention results for the last 12-month requalification period ending in January of 2022 of
For the fourth quarter 2021, net sales declined
During the quarter, the Indian business continued its growth trajectory with a year-over-year increase in net sales of
Looking to the future, the Company has initiated full year 2022 guidance, including net sales in the range of flat to
The Company also has announced details related to its transformation program, which will realign the Company and its employees to better support distributors and their customers, as well as invest in technology for the future. For the first phase of the program, the Company expects total pre-tax charges in the range of
“Investing in the future of our business remains a key priority, as well as identifying opportunities for efficiencies and improvements in productivity in order to drive long-term shareholder value,” said CFO
Fourth Quarter and Full Year 2021 Key Metrics
Regional
Region |
Reported Net
|
Growth/Decline
|
Growth/Decline
|
|
|
$ |
397.3 |
|
|
|
$ |
302.3 |
( |
( |
EMEA |
$ |
291.6 |
( |
( |
|
$ |
130.4 |
( |
( |
|
$ |
109.2 |
( |
( |
South & |
$ |
87.2 |
( |
* |
Worldwide Total |
$ |
1,318.0 |
( |
* |
South & |
$ |
86.7 |
( |
( |
Worldwide Total excl |
$ |
1,317.5 |
( |
( |
Region |
Reported Net
|
Growth/Decline
|
Growth/Decline
|
|
|
$ |
1,586.1 |
|
|
|
$ |
1,428.9 |
|
|
EMEA |
$ |
1,335.4 |
|
|
|
$ |
629.5 |
( |
( |
|
$ |
463.7 |
|
|
South & |
$ |
359.2 |
( |
* |
Worldwide Total |
$ |
5,802.8 |
|
* |
South & |
$ |
357.5 |
( |
|
Worldwide Total excl |
$ |
5,801.1 |
|
|
(a) Growth/decline in net sales excluding the effects of foreign exchange is based on “net sales in local currency,” a non-GAAP financial measure. See Schedule A – “Reconciliation of Non-GAAP Financial Measures” for a discussion of why we believe adjusting for the effects of foreign exchange is useful. |
|
(b) |
|
* Figure not meaningful due to significant foreign currency fluctuations in |
Regional Volume Point Metrics
|
Volume Points |
Volume Points |
||
Region |
4Q '21 (mil) |
Yr/Yr % Chg |
FY '21 (mil) |
Yr/Yr % Chg |
|
490.6 |
|
1,960.1 |
|
|
374.0 |
( |
1,783.8 |
|
EMEA |
369.3 |
( |
1,629.3 |
|
|
76.8 |
( |
375.8 |
( |
|
210.2 |
( |
851.0 |
( |
South & |
123.5 |
( |
497.8 |
( |
Worldwide Total |
1,644.4 |
( |
7,097.8 |
|
Outlook
Following is the Company’s first quarter and full year 2022 guidance based on current business trends:
Three Months Ending |
Twelve Months Ending |
|||
|
|
|||
Low |
High |
Low |
High |
|
Volume Point Growth vs 2021 |
( |
( |
( |
|
Net Sales Growth vs 2021 (a) |
( |
( |
|
|
Adjusted Diluted EPS (a) (b) (c) |
|
|
|
|
Adjusted EBITDA ($ millions) (a) (c) |
|
|
|
|
Cap Ex ($ millions) |
- |
- |
|
|
Currency Fluctuation in Guidance
-
Guidance is based on the average daily exchange rates for the first three weeks of
January 2022 .
-
For the first quarter 2022, net sales guidance includes a projected currency headwind of approximately 240bps, adjusted(a)(b)(c) diluted EPS guidance includes a projected currency headwind of approximately
$0.03 $4 million
-
For the full year 2022, net sales guidance includes a projected currency headwind of approximately 160bps, adjusted(a)(b)(c) diluted EPS guidance includes a projected currency headwind of approximately
$0.17 $21 million
-
Net sales, adjusted(a)(b)(c) diluted EPS, and adjusted(a)(b)(c) EBITDA represent projections translated into US dollars at currency rates equal to the average rates used to translate 2021 first quarter and full year net sales and diluted EPS and adjusted for items such as hedging gains/losses and
Venezuela to be directly comparable to 2021 values. See our Company’s Form 10-K for the year endedDecember 31, 2021 and Schedule A – “Reconciliation of Non-GAAP Financial Measures” for a discussion of why we believe adjusting for the effects of foreign exchange is useful.
Share Repurchase in Guidance
-
With respect to guidance, the Company has assumed
$50 million
(a) Excludes any future potential |
|
(b) Excludes the following items that cannot be accurately predicted: any future potential ongoing tax effects from the exercise or vesting of equity awards that could impact the Company's tax rate due to the stock compensation accounting standard, as well as any future potential dilution from the Company’s convertible notes due in 2024. |
|
(c) Adjusted diluted EPS and adjusted EBITDA guidance are non-GAAP measures and exclude potential charges or gains that may be recorded during the applicable period, such as, among other things, loss contingencies, gain/loss on debt extinguishments and refinancing, tax charges relating to tax law changes, net expenses related to the COVID-19 pandemic, and other unanticipated charges and events. The Company does not provide reconciliations of forward-looking non-GAAP Adjusted diluted EPS and adjusted EBITDA guidance to net income, the comparable GAAP measure, because the impact and timing of these potential charges and gains cannot be determined without unreasonable efforts due to their inherent historical variability, complexity, and unpredictability. These items, which are necessary for a presentation of the reconciliation to GAAP, could have a potentially significant impact on the Company’s GAAP results. |
Earnings Conference Call
The dial-in number for this conference call for domestic callers is (833) 962-1459, and (956) 394-3596 for international callers (conference ID: 5170349). Live audio of the conference call will be simultaneously webcast in the investor relations section of the Company's website at http://ir.Herbalife.com.
An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID: 5170349). The webcast of the teleconference will be archived and available on
About
For more information, please visit https://iamherbalifenutrition.com/.
Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results or outcomes could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by the COVID-19 pandemic. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include the following:
- the potential impacts of the COVID-19 pandemic on us; our Members, customers, and supply chain; and the world economy;
- our ability to attract and retain Members;
- our relationship with, and our ability to influence the actions of, our Members;
-
our noncompliance with, or improper action by our employees or Members in violation of, applicable
U.S. and foreign laws, rules, and regulations; - adverse publicity associated with our Company or the direct-selling industry, including our ability to comfort the marketplace and regulators regarding our compliance with applicable laws;
- changing consumer preferences and demands and evolving industry standards, including with respect to climate change, sustainability, and other environmental, social, and governance, or ESG, matters;
- the competitive nature of our business and industry;
- legal and regulatory matters, including regulatory actions concerning, or legal challenges to, our products or network marketing program and product liability claims;
-
the Consent Order entered into with the
FTC , the effects thereof and any failure to comply therewith; -
risks associated with operating internationally and in
China ; - our ability to execute our growth and other strategic initiatives, including implementation of our transformation program and increased penetration of our existing markets;
- any material disruption to our business caused by natural disasters, other catastrophic events, acts of war or terrorism, cybersecurity incidents, pandemics, and/or other acts by third parties;
- our ability to adequately source ingredients, packaging materials, and other raw materials and manufacture and distribute our products;
- our reliance on our information technology infrastructure;
- noncompliance by us or our Members with any privacy laws, rules, or regulations or any security breach involving the misappropriation, loss, or other unauthorized use or disclosure of confidential information;
- contractual limitations on our ability to expand or change our direct-selling business model;
- the sufficiency of our trademarks and other intellectual property;
- product concentration;
- our reliance upon, or the loss or departure of any member of, our senior management team;
- restrictions imposed by covenants in the agreements governing our indebtedness;
- risks related to our convertible notes;
- changes in, and uncertainties relating to, the application of transfer pricing, income tax, customs duties, value added taxes, and other tax laws, treaties, and regulations, or their interpretation;
-
our incorporation under the laws of the
Cayman Islands ; and - share price volatility related to, among other things, speculative trading and certain traders shorting our common shares.
We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
Results of Operations
| Condensed Consolidated Statements of Income | |||||||||||||||
| (In millions, except per share amounts) | |||||||||||||||
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| (unaudited) | |||||||||||||||
$ |
302.3 |
$ |
310.5 |
|
$ |
1,428.9 |
|
$ |
1,372.9 |
|
|||||
| EMEA |
|
291.6 |
|
315.0 |
|
|
1,335.4 |
|
|
1,208.3 |
|
||||
|
397.3 |
|
377.9 |
|
|
1,586.1 |
|
|
1,347.7 |
|
|||||
|
109.2 |
|
115.3 |
|
|
463.7 |
|
|
436.9 |
|
|||||
|
130.4 |
|
190.2 |
|
|
629.5 |
|
|
809.6 |
|
|||||
| South and |
|
87.2 |
|
101.8 |
|
|
359.2 |
|
|
366.4 |
|
||||
| Worldwide |
|
1,318.0 |
|
1,410.7 |
|
|
5,802.8 |
|
|
5,541.8 |
|
||||
| Cost of Sales |
|
296.6 |
|
309.4 |
|
|
1,239.3 |
|
|
1,150.6 |
|
||||
| Gross Profit |
|
1,021.4 |
|
1,101.3 |
|
|
4,563.5 |
|
|
4,391.2 |
|
||||
| Royalty Overrides |
|
423.9 |
|
438.9 |
|
|
1,833.7 |
|
|
1,690.1 |
|
||||
| Selling, General, and Administrative Expenses |
|
513.2 |
|
515.5 |
|
|
2,012.1 |
|
|
2,075.0 |
|
||||
| Other Operating Income (1) |
|
- |
|
(1.5 |
) |
|
(16.4 |
) |
|
(14.5 |
) |
||||
| Operating Income |
|
84.3 |
|
148.4 |
|
|
734.1 |
|
|
640.6 |
|
||||
| Interest Expense, net |
|
36.7 |
|
35.2 |
|
|
148.7 |
|
|
124.2 |
|
||||
| Other Expense, net (2) |
|
- |
|
- |
|
|
24.6 |
|
|
- |
|
||||
| Income Before Income Taxes |
|
47.6 |
|
113.2 |
|
|
560.8 |
|
|
516.4 |
|
||||
| Income Taxes |
|
9.4 |
|
39.4 |
|
|
113.6 |
|
|
143.8 |
|
||||
| Net Income | $ |
38.2 |
$ |
73.8 |
|
$ |
447.2 |
|
$ |
372.6 |
|
||||
| Weighted-Average Shares Outstanding: | |||||||||||||||
| Basic |
|
101.6 |
|
121.3 |
|
|
105.9 |
|
|
131.5 |
|
||||
| Diluted |
|
103.6 |
|
124.3 |
|
|
108.3 |
|
|
134.5 |
|
||||
| Earnings Per Share: | |||||||||||||||
| Basic | $ |
0.38 |
$ |
0.61 |
|
$ |
4.22 |
|
$ |
2.83 |
|
||||
| Diluted | $ |
0.37 |
$ |
0.59 |
|
$ |
4.13 |
|
$ |
2.77 |
|
||||
(1) Other Operating Income for the three months ended |
|||||||||||||||
(2) Other Expense, net for the twelve months ended |
|||||||||||||||
| Condensed Consolidated Balance Sheets | |||||||||
| (In millions) | |||||||||
|
|
|
|||||||
2021 |
|
2020 |
|||||||
| ASSETS | |||||||||
| Current Assets: | |||||||||
| Cash and cash equivalents | $ |
601.5 |
|
$ |
1,045.4 |
|
|||
| Receivables, net |
|
66.9 |
|
|
83.3 |
|
|||
| Inventories |
|
575.7 |
|
|
501.4 |
|
|||
| Prepaid expenses and other current assets |
|
187.7 |
|
|
145.7 |
|
|||
| Total Current Assets |
|
1,431.8 |
|
|
1,775.8 |
|
|||
| Property, plant and equipment, net |
|
442.1 |
|
|
390.2 |
|
|||
| Operating lease right-of-use assets |
|
220.0 |
|
|
222.8 |
|
|||
| Marketing-related intangibles and other intangible assets, net |
|
317.3 |
|
|
313.3 |
|
|||
|
95.4 |
|
|
100.5 |
|
||||
| Other assets |
|
313.2 |
|
|
273.5 |
|
|||
| Total Assets | $ |
2,819.8 |
|
$ |
3,076.1 |
|
|||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | |||||||||
| Current Liabilities: | |||||||||
| Accounts payable | $ |
92.0 |
|
$ |
88.7 |
|
|||
| Royalty overrides |
|
363.2 |
|
|
358.2 |
|
|||
| Current portion of long-term debt |
|
29.4 |
|
|
22.9 |
|
|||
| Other current liabilities |
|
595.8 |
|
|
657.5 |
|
|||
| Total Current Liabilities |
|
1,080.4 |
|
|
1,127.3 |
|
|||
| Non-current liabilities: | |||||||||
| Long-term debt, net of current portion |
|
2,733.2 |
|
|
2,405.5 |
|
|||
| Non-current operating lease liabilities |
|
201.2 |
|
|
206.7 |
|
|||
| Other non-current liabilities |
|
196.5 |
|
|
192.7 |
|
|||
| Total Liabilities |
|
4,211.3 |
|
|
3,932.2 |
|
|||
| Commitments and Contingencies | |||||||||
| Shareholders' deficit: | |||||||||
| Common shares |
|
0.1 |
|
|
0.1 |
|
|||
| Paid-in capital in excess of par value |
|
318.1 |
|
|
342.3 |
|
|||
| Accumulated other comprehensive loss |
|
(211.8 |
) |
|
(182.2 |
) |
|||
| Accumulated deficit |
|
(1,169.0 |
) |
|
(687.4 |
) |
|||
|
(328.9 |
) |
|
(328.9 |
) |
||||
| Total Shareholders' Deficit |
|
(1,391.5 |
) |
|
(856.1 |
) |
|||
| Total Liabilities and Shareholders' Deficit | $ |
2,819.8 |
|
$ |
3,076.1 |
|
|||
| Condensed Consolidated Statements of Cash Flows | |||||||||
| (In millions) | |||||||||
| Twelve Months Ended | |||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||
| Net income | $ |
447.2 |
|
$ |
372.6 |
|
|||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||
| Depreciation and amortization |
|
107.6 |
|
|
100.3 |
|
|||
| Share-based compensation expenses |
|
54.1 |
|
|
51.0 |
|
|||
| Non-cash interest expense |
|
30.1 |
|
|
26.7 |
|
|||
| Deferred income taxes |
|
(33.3 |
) |
|
2.0 |
|
|||
| Inventory write-downs |
|
28.8 |
|
|
20.6 |
|
|||
| Foreign exchange transaction loss |
|
14.3 |
|
|
9.9 |
|
|||
| Loss on extinguishment of debt |
|
24.6 |
|
|
- |
|
|||
| Other |
|
5.2 |
|
|
5.3 |
|
|||
| Changes in operating assets and liabilities: | |||||||||
| Receivables |
|
9.6 |
|
|
(5.8 |
) |
|||
| Inventories |
|
(129.1 |
) |
|
(76.6 |
) |
|||
| Prepaid expenses and other current assets |
|
(49.3 |
) |
|
(11.9 |
) |
|||
| Accounts payable |
|
6.9 |
|
|
5.5 |
|
|||
| Royalty overrides |
|
17.8 |
|
|
61.2 |
|
|||
| Other current liabilities |
|
(68.8 |
) |
|
77.6 |
|
|||
| Other |
|
(5.4 |
) |
|
(9.8 |
) |
|||
| NET CASH PROVIDED BY OPERATING ACTIVITIES |
|
460.3 |
|
|
628.6 |
|
|||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||
| Purchases of property, plant and equipment |
|
(151.4 |
) |
|
(112.0 |
) |
|||
| Other |
|
(5.0 |
) |
|
(11.2 |
) |
|||
|
(156.4 |
) |
|
(123.2 |
) |
||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||
| Borrowings from senior secured credit facility, net of discount |
|
671.1 |
|
|
31.5 |
|
|||
| Principal payments on senior secured credit facility and other debt |
|
(563.5 |
) |
|
(24.5 |
) |
|||
| Proceeds from senior notes |
|
600.0 |
|
|
600.0 |
|
|||
| Repayment of senior notes |
|
(420.7 |
) |
|
- |
|
|||
| Debt issuance cost |
|
(8.4 |
) |
|
(7.9 |
) |
|||
| Share repurchases |
|
(1,011.3 |
) |
|
(923.5 |
) |
|||
| Other |
|
4.2 |
|
|
3.5 |
|
|||
|
(728.6 |
) |
|
(320.9 |
) |
||||
| EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH |
|
(18.9 |
) |
|
22.0 |
|
|||
| NET CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH |
|
(443.6 |
) |
|
206.5 |
|
|||
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF PERIOD |
|
1,054.0 |
|
|
847.5 |
|
|||
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD | $ |
610.4 |
|
$ |
1,054.0 |
|
|||
| Cash paid during the year: | |||||||||
| Interest paid | $ |
143.5 |
|
$ |
78.9 |
|
|||
| Income taxes paid | $ |
156.3 |
|
$ |
138.2 |
|
|||
Supplemental Information
SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(Unaudited and unreviewed), (All tables provide Dollars in millions, except per Share Data)
Adjusted Net Income, Adjusted Diluted EPS and Adjusted EBITDA
In addition to its reported results and guidance calculated in accordance with GAAP, the Company has included in this release adjusted net income, adjusted diluted EPS and adjusted EBITDA, performance measures that the
Currency Fluctuation
Our international operations have provided and will continue to provide a significant portion of our total net sales. As a result, total net sales will continue to be affected by fluctuations in the
In addition, the impact of foreign currency fluctuations in
The following is a reconciliation of net income, presented and reported in accordance with
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| (in millions) | |||||||||||||||
| Net income, as reported | $ |
38.2 |
|
$ |
73.8 |
$ |
447.2 |
|
$ |
372.6 |
|
||||
| Expenses related to regulatory inquiries and legal accruals (1) (2) (3) (4) |
|
12.5 |
|
|
0.2 |
|
12.5 |
|
|
85.9 |
|
||||
| Non-cash interest expense and amortization of non-cash issuance costs (1) (2) (5) |
|
6.1 |
|
|
5.6 |
|
23.7 |
|
|
21.8 |
|
||||
| Debt issuance costs related to the senior secured credit facility amendment (1) (2) (6) |
|
- |
|
|
- |
|
1.7 |
|
|
0.5 |
|
||||
| Net expenses related to COVID-19 pandemic (1) (2) |
|
2.0 |
|
|
4.6 |
|
13.8 |
|
|
21.2 |
|
||||
| Loss on extinguishment of debt (1) (2) (7) |
|
- |
|
|
- |
|
24.6 |
|
|
- |
|
||||
| Non-income tax items, net (1) (2) (8) |
|
- |
|
|
- |
|
(7.4 |
) |
|
- |
|
||||
| Expenses related to transformation program (1) (2) |
|
5.3 |
|
|
- |
|
12.9 |
|
|
- |
|
||||
| Income tax adjustments for above items (1) (2) |
|
(4.8 |
) |
|
4.0 |
|
(10.9 |
) |
|
(2.6 |
) |
||||
| Net income, as adjusted (9) | $ |
59.3 |
|
$ |
88.1 |
$ |
518.0 |
|
$ |
499.4 |
|
||||
The following is a reconciliation of diluted earnings per share, presented and reported in accordance with
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| (per share) | |||||||||||||||
| Diluted earnings per share, as reported | $ |
0.37 |
|
$ |
0.59 |
$ |
4.13 |
|
$ |
2.77 |
|
||||
| Expenses related to regulatory inquiries and legal accruals (1) (2) (3) (4) |
|
0.12 |
|
|
- |
|
0.12 |
|
|
0.64 |
|
||||
| Non-cash interest expense and amortization of non-cash issuance costs (1) (2) (5) |
|
0.06 |
|
|
0.05 |
|
0.22 |
|
|
0.16 |
|
||||
| Debt issuance costs related to the senior secured credit facility amendment (1) (2) (6) |
|
- |
|
|
- |
|
0.02 |
|
|
- |
|
||||
| Net expenses related to COVID-19 pandemic (1) (2) |
|
0.02 |
|
|
0.04 |
|
0.13 |
|
|
0.16 |
|
||||
| Loss on extinguishment of debt (1) (2) (7) |
|
- |
|
|
- |
|
0.23 |
|
|
- |
|
||||
| Non-income tax items, net (1) (2) (8) |
|
- |
|
|
- |
|
(0.07 |
) |
|
- |
|
||||
| Expenses related to transformation program (1) (2) |
|
0.05 |
|
|
- |
|
0.12 |
|
|
- |
|
||||
| Income tax adjustments for above items (1) (2) |
|
(0.05 |
) |
|
0.03 |
|
(0.10 |
) |
|
(0.01 |
) |
||||
| Adjusted diluted earnings per adjusted share (9) | $ |
0.57 |
|
$ |
0.71 |
$ |
4.79 |
|
$ |
3.71 |
|
||||
The following is a reconciliation of net income, presented and reported in accordance with
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| (in millions) | |||||||||||||||
| Net income, as reported | $ |
38.2 |
$ |
73.8 |
$ |
447.2 |
|
$ |
372.6 |
||||||
| Interest Expense, net |
|
36.7 |
|
|
35.2 |
|
148.7 |
|
|
124.2 |
|
||||
| Income Taxes |
|
9.4 |
|
|
39.4 |
|
113.6 |
|
|
143.8 |
|
||||
| Depreciation and amortization |
|
27.5 |
|
|
26.0 |
|
107.6 |
|
|
100.3 |
|
||||
| EBITDA | $ |
111.8 |
|
$ |
174.4 |
$ |
817.1 |
|
$ |
740.9 |
|
||||
| Expenses related to regulatory inquiries and legal accruals (1) (2) (3) (4) |
|
12.5 |
|
|
0.2 |
|
12.5 |
|
|
85.9 |
|
||||
| Net expenses related to COVID-19 pandemic (1) (2) |
|
2.0 |
|
|
4.6 |
|
13.8 |
|
|
21.2 |
|
||||
| Loss on extinguishment of debt (1) (2) (7) |
|
- |
|
|
- |
|
24.6 |
|
|
- |
|
||||
| Non-income tax items, net (1) (2) (8) |
|
- |
|
|
- |
|
(7.4 |
) |
|
- |
|
||||
| Expenses related to transformation program (1) (2) |
|
5.3 |
|
|
- |
|
12.9 |
|
|
- |
|
||||
| Adjusted EBITDA | $ |
131.6 |
|
$ |
179.2 |
$ |
873.5 |
|
$ |
848.0 |
|
||||
| (1) Based on interim income tax reporting rules, these expenses are not considered discrete items. The tax effect of the adjustments between our GAAP and non-GAAP results takes into account the tax treatment and related tax rate(s) that apply to each adjustment in the applicable tax jurisdiction(s). | |||||||||||||||
| (2) Excludes tax (benefit)/expense as follows: | |||||||||||||||
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| (in millions) | |||||||||||||||
| Expenses related to regulatory inquiries and legal accruals | $ |
(2.9 |
) |
$ |
4.2 |
|
$ |
(2.9 |
) |
$ |
(0.5 |
) |
|||
| Non-cash interest expense and amortization of non-cash issuance costs |
|
(0.7 |
) |
|
(0.2 |
) |
|
- |
|
|
- |
|
|||
| Debt issuance costs related to the senior secured credit facility amendment |
|
(0.1 |
) |
|
- |
|
|
(0.4 |
) |
|
(0.1 |
) |
|||
| Net expenses related to COVID-19 pandemic |
|
(0.5 |
) |
|
- |
|
|
(2.6 |
) |
|
(2.0 |
) |
|||
| Loss on extinguishment of debt |
|
- |
|
|
- |
|
|
(5.5 |
) |
|
- |
|
|||
| Non-income tax items, net |
|
- |
|
|
- |
|
|
1.8 |
|
|
- |
|
|||
| Expenses related to transformation program |
|
(0.7 |
) |
|
- |
|
|
(1.4 |
) |
|
- |
|
|||
| Total income tax adjustments (9) | $ |
(4.8 |
) |
$ |
4.0 |
|
$ |
(10.9 |
) |
$ |
(2.6 |
) |
|||
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| (per share) | |||||||||||||||
| Expenses related to regulatory inquiries and legal accruals | $ |
(0.03 |
) |
$ |
0.03 |
|
$ |
(0.03 |
) |
$ |
- |
|
|||
| Non-cash interest expense and amortization of non-cash issuance costs |
|
(0.01 |
) |
|
- |
|
|
- |
|
|
- |
|
|||
| Debt issuance costs related to the senior secured credit facility amendment |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|||
| Net expenses related to COVID-19 pandemic |
|
- |
|
|
- |
|
|
(0.02 |
) |
|
(0.01 |
) |
|||
| Loss on extinguishment of debt |
|
- |
|
|
- |
|
|
(0.05 |
) |
|
- |
|
|||
| Non-income tax items, net |
|
- |
|
|
- |
|
|
0.02 |
|
|
- |
|
|||
| Expenses related to transformation program |
|
(0.01 |
) |
|
- |
|
|
(0.01 |
) |
|
- |
|
|||
| Total income tax adjustments (9) | $ |
(0.05 |
) |
$ |
0.03 |
|
$ |
(0.10 |
) |
$ |
(0.01 |
) |
|||
| (3) Includes legal accrual recorded during the twelve months ended |
|||||||||||||||
| (4) Amounts for the three and twelve months ended |
|||||||||||||||
| (5) Relates to non-cash expense on the Company's |
|||||||||||||||
| (6) Relates to costs incurred in the amendment of the senior secured credit facility as described in the Company's Form 10-K for the year ended |
|||||||||||||||
| (7) Relates to the loss on the extinguishment of the senior notes due 2026. | |||||||||||||||
| (8) Relates to certain non-income tax assessments, recoveries and credits. | |||||||||||||||
| (9) Amounts may not total due to rounding. | |||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20220223005444/en/
Media Contact:
VP, Media Relations
213.745.0420
Investor Contact:
Senior Director, Investor Relations
213.745.0449
Source:
FAQ
What were Herbalife's 2021 financial results?
What is Herbalife's guidance for net sales growth in 2022?
How many new distributors did Herbalife add in 2021?
What was the decline in net sales for the fourth quarter of 2021?
What are Herbalife's adjusted EPS expectations for 2022?
